MedTrace Logo

Long-term With a Trifocal Intraocular Lens

NCT04861909 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2021-04-27

No results posted yet for this study

Summary

The main aims of this study were to evaluate the patient reported outcomes (PROs), safety and efficacy, after 6-year (66 - 78 months) from the binocular implantation of the AT LISA tri 839MP. A secondary aim was to evaluate new metrics such as contrast sensitivity defocus curves and light distortion analysis.

Conditions

  • Cataract

Interventions

DEVICE

AT LISA tri 839MP

Non interventional study

Sponsors & Collaborators

  • Carl Zeiss Meditec AG

    collaborator INDUSTRY

  • Qvision, Ophthalmology Department

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-15
Primary Completion
2020-11-24
Completion
2020-11-24

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04861909 on ClinicalTrials.gov